Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI
- Conditions
- Screening Breast MRI in Patients Who Are BRCA Mutation Carriers
- Interventions
- Device: MRIBehavioral: Optional Screening Questionnaire
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 63
- Registration Number
- NCT02462460
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Irreversible Electroporation Ablation for Colorectal Metastases to the Lung
- Conditions
- Colorectal Metastases to the Lung
- Interventions
- Device: Irreversible Electroporation Ablation
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2018-01-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT02461550
- Locations
- 🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering West Harrison, Harrison, New York, United States
Identifying Family Members in Need of Support While Caregiving and After Loss
- Conditions
- Advanced Cancer
- Interventions
- Behavioral: background questionnaireBehavioral: bereavement risk screening tool
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 52
- Registration Number
- NCT02455505
- Locations
- 🇺🇸
Calvary Hospital, Bronx, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations
- Conditions
- Oligometastatic Lung Adenocarcinoma
- Interventions
- Other: Local Therapies
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2018-05-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT02450591
- Locations
- 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
- Conditions
- Leukemia
- Interventions
- Genetic: KIR genotypingGenetic: HLA genotyping
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 511
- Registration Number
- NCT02450708
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
🇺🇸Md Anderson Cancer Center, Houston, Texas, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2015-05-07
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT02437071
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies
- Conditions
- Lung Cancer
- Interventions
- Procedure: Bronchoscopic ImplantationDevice: Cone-Beam CT-GuidedRadiation: stereotactic body radiation treatments
- First Posted Date
- 2015-05-05
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT02434809
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary
- Conditions
- Recurrent Brain MetastasesProgressive Brain Metastases
- Interventions
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT02429570
- Locations
- 🇺🇸
Baptist Health South Florida, Miami, Florida, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2022-05-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT02429375
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
- Conditions
- Radiation Therapy
- Interventions
- Device: MRI or CT
- First Posted Date
- 2015-04-21
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 567
- Registration Number
- NCT02422550
- Locations
- 🇺🇸
Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States